Apotex alleged that selected US court judgments and FDA selections discriminated in opposition to it, denied it minimal typical of cure and expropriated its investment in pravastatin. Damages sought: US$8 million.Although different US constituents have expressed significant problems about and opposition to the NAFTA dispute resolution system, it ca